 |
Prescription and Over-the-Counter Drug Product List
25th Edition
Cumulative Supplement Number 4: April 2006
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; CODEINE PHOSPHATE
TABLET; ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
>D> AA TEVA 300MG;60MG N88629 001 Mar 06, 1985 Apr CRLD
>A> AA + 300MG;60MG N88629 001 Mar 06, 1985 Apr CRLD
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
OXYCODONE AND ACETAMINOPHEN
>A> + MIKART 400MG;5MG N40687 001 Apr 27, 2006 Apr NEWA
>A> + 400MG;7.5MG N40698 001 Apr 27, 2006 Apr NEWA
>A> + 400MG;10MG N40692 001 Apr 27, 2006 Apr NEWA
>A> 500MG;10MG N40676 001 Apr 19, 2006 Apr NEWA
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE; ORAL
LOTREL
>A> NOVARTIS EQ 5MG BASE;40MG N20364 007 Apr 11, 2006 Apr NEWA
>D> + EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 Apr CRLD
>A> EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 Apr CRLD
>A> + EQ 10MG BASE;40MG N20364 006 Apr 11, 2006 Apr NEWA
>D> ARTICAINE HYDROCHLORIDE; EPINEPHRINE
>D> INJECTABLE; INJECTION
>D> SEPTOCAINE
>D> DEPROCO 4%;EQ 0.005MG BASE/ML N22010 001 Mar 30, 2006 Apr CAIN
>D> + 4%; EQ 0.017MG BASE/1.7ML (4%; EQ N20971 001 Apr 03, 2000 Apr CAIN
>A> ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
>A> INJECTABLE; INJECTION
>A> SEPTOCAINE
>A> + DEPROCO 4%;EQ 0.0085MG BASE/1.7ML(4%; EQ N22010 001 Mar 30, 2006 Apr CAIN
>A> + 4%; EQ 0.017MG BASE/1.7ML (4%; EQ N20971 001 Apr 03, 2000 Apr CAIN
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
CAPSULE; ORAL
>A> FIORINAL W/CODEINE
>A> AB + WATSON PHARMS 325MG;50MG;40MG;30MG N19429 003 Oct 26, 1990 Apr CTNA
>D> FIORINAL W/CODEINE NO 3
>D> AB + WATSON PHARMS 325MG;50MG;40MG;30MG N19429 003 Oct 26, 1990 Apr CTNA
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL
>A> BENZPHETAMINE HYDROCHLORIDE
>A> AA PADDOCK 50MG N40578 001 Apr 17, 2006 Apr NEWA
DIDREX
>D> + PHARMACIA AND 50MG N12427 002 Apr CFTG
>A> AA + 50MG N12427 002 Apr CFTG
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE
>A> + HOSPIRA 0.5% N22046 002 Jul 13, 1983 Apr NEWA
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE
>A> + HOSPIRA 0.5%;EQ 0.009MG BASE/ML N22046 001 Jul 13, 1983 Apr NEWA
CEFTRIAXONE
INJECTABLE; INJECTION
CEFTRIAXONE
>A> AP TEVA EQ 10GM BASE/VIAL N65274 001 May 01, 2006 Apr NEWA
CILOSTAZOL
TABLET; ORAL
CILOSTAZOL
>A> AB MYLAN 50MG N77323 002 Apr 20, 2006 Apr NEWA
>A> AB 100MG N77323 001 Apr 20, 2006 Apr NEWA
CLARITHROMYCIN
TABLET, EXTENDED RELEASE; ORAL
CLARITHROMYCIN
>D> RANBAXY 1GM N65210 001 Jan 26, 2005 Apr CRLD
>A> + 1GM N65210 001 Jan 26, 2005 Apr CRLD
COLESTIPOL HYDROCHLORIDE
GRANULE; ORAL
COLESTID
>D> PHARMACIA AND 5GM/SCOOPFUL N17563 003 Sep 22, 1995 Apr CFTG
>A> AB 5GM/SCOOPFUL N17563 003 Sep 22, 1995 Apr CFTG
>D> + 5GM/PACKET N17563 004 Sep 22, 1995 Apr CFTG
>A> AB + 5GM/PACKET N17563 004 Sep 22, 1995 Apr CFTG
>A> COLESTIPOL HYDROCHLORIDE
>A> AB IMPAX LABS 5GM/SCOOPFUL N77277 001 May 02, 2006 Apr NEWA
>A> AB 5GM/PACKET N77277 002 May 02, 2006 Apr NEWA
FLAVORED COLESTID
>D> + PHARMACIA AND 5GM/PACKET N17563 001 Apr CRLD
>A> 5GM/PACKET N17563 001 Apr CRLD
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
CYCL0BENZAPRINE HYDROCHLORIDE
>A> AB JUBILANT PHARMS 5MG N77563 001 Apr 19, 2006 Apr NEWA
>A> AB 10MG N77563 002 Apr 19, 2006 Apr NEWA
DIPYRIDAMOLE
TABLET; ORAL
DIPYRIDAMOLE
>A> AB AMIDE PHARM 25MG N40542 001 Apr 21, 2006 Apr NEWA
>A> AB 50MG N40542 002 Apr 21, 2006 Apr NEWA
>A> AB 75MG N40542 003 Apr 21, 2006 Apr NEWA
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DOPAMINE HYDROCHLORIDE
>D> AP + HOSPIRA 40MG/ML N74403 001 May 23, 1996 Apr DISC
>A> @ 40MG/ML N74403 001 May 23, 1996 Apr DISC
>D> AP + INTL MEDICATION 40MG/ML N18014 001 Apr DISC
>A> @ 40MG/ML N18014 001 Apr DISC
>D> AP + SICOR PHARMS 40MG/ML N72999 001 Oct 23, 1991 Apr DISC
>A> @ 40MG/ML N72999 001 Oct 23, 1991 Apr DISC
>D> AP + 80MG/ML N73000 001 Oct 23, 1991 Apr DISC
>A> @ 80MG/ML N73000 001 Oct 23, 1991 Apr DISC
DOXYCYCLINE HYCLATE
CAPSULE, DELAYED RELEASE; ORAL
DORYX
>D> AB FH FAULDING CO LTD EQ 75MG BASE N50582 002 Aug 13, 2001 Apr DISC
>A> @ EQ 75MG BASE N50582 002 Aug 13, 2001 Apr DISC
>D> AB + EQ 100MG BASE N50582 001 Jul 22, 1985 Apr DISC
>A> @ EQ 100MG BASE N50582 001 Jul 22, 1985 Apr DISC
>D> AB WARNER CHILCOTT EQ 100MG BASE N62653 001 Oct 30, 1985 Apr DISC
>A> @ EQ 100MG BASE N62653 001 Oct 30, 1985 Apr DISC
DOXYCYCLINE HYCLATE
>D> AB SANDOZ EQ 75MG BASE N65281 001 Dec 21, 2005 Apr CTEC
>A> EQ 75MG BASE N65281 001 Dec 21, 2005 Apr CTEC
>D> AB EQ 100MG BASE N65281 002 Dec 21, 2005 Apr CRLD
>A> + EQ 100MG BASE N65281 002 Dec 21, 2005 Apr CRLD
ESTAZOLAM
TABLET; ORAL
ESTAZOLAM
>D> AB IVAX PHARMS 1MG N74826 001 Jul 03, 1997 Apr CAHN
>D> AB 2MG N74826 002 Jul 03, 1997 Apr CAHN
>A> AB PAR PHARM 1MG N74826 001 Jul 03, 1997 Apr CAHN
>A> AB 2MG N74826 002 Jul 03, 1997 Apr CAHN
FLUOROURACIL
INJECTABLE; INJECTION
FLUOROURACIL
>D> AP + BEDFORD 50MG/ML N89508 001 Jan 26, 1988 Apr DISC
>A> @ 50MG/ML N89508 001 Jan 26, 1988 Apr DISC
>D> AP + STERIS 50MG/ML N87792 001 Oct 13, 1982 Apr DISC
>A> @ WATSON LABS 50MG/ML N87792 001 Oct 13, 1982 Apr DISC
FLUPHENAZINE HYDROCHLORIDE
ELIXIR; ORAL
FLUPHENAZINE HYDROCHLORIDE
>D> AA PHARM ASSOC 2.5MG/5ML N40146 001 Aug 21, 1996 Apr CRLD
>A> + 2.5MG/5ML N40146 001 Aug 21, 1996 Apr CRLD
>D> AA TEVA PHARMS 2.5MG/5ML N81310 001 Apr 29, 1993 Apr DISC
>A> @ 2.5MG/5ML N81310 001 Apr 29, 1993 Apr DISC
>D> PROLIXIN
>D> AA + APOTHECON 2.5MG/5ML N12145 003 Apr DISC
>A> @ 2.5MG/5ML N12145 003 Apr DISC
FLUTAMIDE
CAPSULE; ORAL
FLUTAMIDE
>A> AB PAR PHARM 125MG N75298 001 Sep 18, 2001 Apr CAHN
>D> AB TEVA 125MG N75298 001 Sep 18, 2001 Apr CAHN
HALOBETASOL PROPIONATE
CREAM; TOPICAL
HALOBETASOL PROPIONATE
>D> AB AGIS INDS 0.05% N77123 001 Dec 16, 2004 Apr CAHN
>A> AB PERRIGO ISRAEL 0.05% N77123 001 Dec 16, 2004 Apr CAHN
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET; ORAL
DIOVAN HCT
>A> NOVARTIS 12.5MG;320MG N20818 004 Apr 28, 2006 Apr NEWA
>D> + 25MG;160MG N20818 003 Jan 17, 2002 Apr CRLD
>A> 25MG;160MG N20818 003 Jan 17, 2002 Apr CRLD
>A> + 25MG;320MG N20818 005 Apr 28, 2006 Apr NEWA
HYDROCORTISONE; NEOMYCIN; POLYMYXIN B SULFATE
SUSPENSION/DROPS; OTIC
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
>A> AT PHARMAFORCE 1%;EQ 3.5MG BASE;10,000 UNITS N65219 001 May 01, 2006 Apr NEWA
IBUPROFEN LYSINE
>A> INJECTABLE; INTRAVENOUS
>A> NEOPROFEN
>A> + FARMACON IL EQ 20MG BASE/2ML (EQ 10MG BASE/ML) N21903 001 Apr 13, 2006 Apr NEWA
INDOMETHACIN
SUPPOSITORY; RECTAL
>A> INDOMETHACIN
>A> + G AND W LABS 50MG N73314 001 Aug 31, 1992 Apr CTNA
>D> INDOMETHEGAN
>D> + G AND W LABS 50MG N73314 001 Aug 31, 1992 Apr CTNA
ISRADIPINE
CAPSULE; ORAL
ISRADIPINE
>D> ABRIKA PHARMS 5MG N77317 002 Jan 05, 2006 Apr CTEC
>A> AB 5MG N77317 002 Jan 05, 2006 Apr CTEC
>A> AB AMIDE PHARM 2.5MG N77169 001 Apr 24, 2006 Apr NEWA
>A> AB 5MG N77169 002 Apr 24, 2006 Apr NEWA
KETOTIFEN FUMARATE
SOLUTION/DROPS; OPHTHALMIC
>A> KETOTIFEN FUMARATE
>A> AT APOTEX EQ 0.025% BASE N77354 001 May 09, 2006 Apr NEWA
ZADITOR
>D> + NOVARTIS EQ 0.025% BASE N21066 001 Jul 02, 1999 Apr CFTG
>A> AT + EQ 0.025% BASE N21066 001 Jul 02, 1999 Apr CFTG
LORAZEPAM
TABLET; ORAL
LORAZEPAM
>A> AB VINTAGE PHARMS 0.5MG N77754 001 May 10, 2006 Apr NEWA
>A> AB 1MG N77754 002 May 10, 2006 Apr NEWA
>A> AB 2MG N77754 003 May 10, 2006 Apr NEWA
LOVASTATIN
TABLET; ORAL
LOVASTATIN
>A> AB MUTUAL PHARM 10MG N77520 001 Apr 14, 2006 Apr NEWA
>A> AB 20MG N77520 002 Apr 14, 2006 Apr NEWA
>A> AB 40MG N77520 003 Apr 14, 2006 Apr NEWA
MESALAMINE
ENEMA; RECTAL
ROWASA
>A> AB + ALAVEN PHARM 4GM/60ML N19618 001 Dec 24, 1987 Apr CAHN
>D> AB + SOLVAY 4GM/60ML N19618 001 Dec 24, 1987 Apr CAHN
>D> METHOTREXATE
>D> INJECTABLE; INJECTION
>D> METHOTREXATE PRESERVATIVE FREE
>D> + BEDFORD EQ 1GM BASE/VIAL N40632 001 Aug 12, 2005 Apr CAIN
>A> METHOTREXATE SODIUM
>A> INJECTABLE; INJECTION
>A> METHOTREXATE PRESERVATIVE FREE
>A> + BEDFORD EQ 1GM BASE/VIAL N40632 001 Aug 12, 2005 Apr CAIN
>D> AP + MAYNE PHARMA USA ED 1GM BASE/40ML (25 MG/ML) N11719 012 Apr 13, 2005 Apr CPOT
>A> + EQ 1GM BASE/40ML (25 MG/ML) N11719 012 Apr 13, 2005 Apr CPOT
METHOTREXATE SODIUM
>D> AP BEDFORD EQ 50 MG BASE/2ML (25 ML/ML) N89340 001 Sep 16, 1986 Apr CPOT
>A> AP + EQ 50MG BASE/2ML (25MG/ML) N89340 001 Sep 16, 1986 Apr CPOT
>D> AP EQ 100MG BASE/4ML (25 MG/ML) N89341 001 Sep 16, 1986 Apr CTEC
>A> + EQ 100MG BASE/4ML (25 MG/ML) N89341 001 Sep 16, 1986 Apr CTEC
>D> AP EQ 200MG BASE/8ML (25 MG/ML) N89342 001 Sep 16, 1986 Apr CTEC
>A> + EQ 200MG BASE/8ML (25 MG/ML) N89342 001 Sep 16, 1986 Apr CTEC
>D> AP EQ 250MG BASE/10ML (25 MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
>A> + EQ 250MG BASE/10ML (25 MG/ML) N89343 001 Sep 16, 1986 Apr CTEC
METHYLPHENIDATE
>A> FILM, EXTENDED RELEASE; TRANSDERMAL
>A> DAYTRANA
>A> + SHIRE 10MG/9HR (1.1MG/HR) N21514 001 Apr 06, 2006 Apr NEWA
>A> + 15MG/9HR (1.6MG/HR) N21514 002 Apr 06, 2006 Apr NEWA
>A> + 20MG/9HR (2.2MG/HR) N21514 003 Apr 06, 2006 Apr NEWA
>A> + 30MG/9HR (3.3MG/HR) N21514 004 Apr 06, 2006 Apr NEWA
METOCLOPRAMIDE HYDROCHLORIDE
TABLET; ORAL
METOCLOPRAMIDE HYDROCHLORIDE
>D> @ MUTUAL PHARM EQ 5MG BASE N71536 002 Jan 16, 1997 Apr CMFD
>A> AB EQ 5MG BASE N71536 002 Jan 16, 1997 Apr CMFD
>D> @ EQ 10MG BASE N71536 001 Apr 28, 1993 Apr CMFD
>A> AB EQ 10MG BASE N71536 001 Apr 28, 1993 Apr CMFD
NABUMETONE
TABLET; ORAL
NABUMETONE
>D> AB IVAX PHARMS 500MG N76009 001 Jan 24, 2003 Apr CAHN
>D> AB 750MG N76009 002 Jan 24, 2003 Apr CAHN
>A> AB PAR PHARM 500MG N76009 001 Jan 24, 2003 Apr CAHN
>A> AB 750MG N76009 002 Jan 24, 2003 Apr CAHN
NAFCILLIN SODIUM
INJECTABLE; INJECTION
NAFCILLIN SODIUM
>D> AP SANDOZ EQ 1GM BASE/VIAL N62732 001 Dec 23, 1986 Apr CRLD
>A> AP + EQ 1GM BASE/VIAL N62732 001 Dec 23, 1986 Apr CRLD
>D> AP EQ 1GM BASE/VIAL N62527 002 Aug 02, 1984 Apr CRLD
>A> AP + EQ 1GM BASE/VIAL N62527 002 Aug 02, 1984 Apr CRLD
>D> AP EQ 2GM BASE/VIAL N62732 002 Dec 23, 1986 Apr CRLD
>A> AP + EQ 2GM BASE/VIAL N62732 002 Dec 23, 1986 Apr CRLD
>D> AP EQ 2GM BASE/VIAL N62527 003 Aug 02, 1984 Apr CRLD
>A> AP + EQ 2GM BASE/VIAL N62527 003 Aug 02, 1984 Apr CRLD
>D> AP EQ 10GM BASE/VIAL N62527 004 Aug 02, 1984 Apr CRLD
>A> AP + EQ 10GM BASE/VIAL N62527 004 Aug 02, 1984 Apr CRLD
NALTREXONE
>A> FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
>A> VIVITROL
>A> + ALKERMES 380MG/VIAL N21897 001 Apr 13, 2006 Apr NEWA
NICARDIPINE HYDROCHLORIDE
CAPSULE; ORAL
NICARDIPINE HYDROCHLORIDE
>A> AB BARR 20MG N74439 001 Dec 10, 1996 Apr CAHN
>A> AB 30MG N74439 002 Dec 10, 1996 Apr CAHN
>D> AB IVAX PHARMS 20MG N74439 001 Dec 10, 1996 Apr CAHN
>D> AB 30MG N74439 002 Dec 10, 1996 Apr CAHN
OXYMETHOLONE
TABLET; ORAL
ANADROL-50
>A> + ALAVEN PHARM 50MG N16848 001 Apr CAHN
>D> + UNIMED PHARMS 50MG N16848 001 Apr CAHN
PACLITAXEL
FOR SUSPENSION; IV (INFUSION)
ABRAXANE
>A> + ABRAXIS BIOSCIENCE 100MG/VIAL N21660 001 Jan 07, 2005 Apr CAHN
>D> + AM BIOSCIENCE 100MG/VIAL N21660 001 Jan 07, 2005 Apr CAHN
PAROXETINE MESYLATE
TABLET; ORAL
PEXEVA
>A> JDS PHARMS EQ 10MG BASE N21299 001 Jul 03, 2003 Apr CAHN
>A> EQ 20MG BASE N21299 002 Jul 03, 2003 Apr CAHN
>A> EQ 30MG BASE N21299 003 Jul 03, 2003 Apr CAHN
>A> + EQ 40MG BASE N21299 004 Jul 03, 2003 Apr CAHN
>D> SYNTHON PHARMS EQ 10MG BASE N21299 001 Jul 03, 2003 Apr CAHN
>D> EQ 20MG BASE N21299 002 Jul 03, 2003 Apr CAHN
>D> EQ 30MG BASE N21299 003 Jul 03, 2003 Apr CAHN
>D> + EQ 40MG BASE N21299 004 Jul 03, 2003 Apr CAHN
PERGOLIDE MESYLATE
TABLET; ORAL
PERGOLIDE MESYLATE
>A> AB PAR PHARM EQ 0.05MG BASE N76061 001 Nov 27, 2002 Apr CAHN
>A> AB EQ 0.25MG BASE N76061 002 Nov 27, 2002 Apr CAHN
>A> AB EQ 1MG BASE N76061 003 Nov 27, 2002 Apr CAHN
>D> AB TEVA EQ 0.05MG BASE N76061 001 Nov 27, 2002 Apr CAHN
>D> AB EQ 0.25MG BASE N76061 002 Nov 27, 2002 Apr CAHN
>D> AB EQ 1MG BASE N76061 003 Nov 27, 2002 Apr CAHN
POLYETHYLENE GLYCOL 3350
FOR SOLUTION; ORAL
POLYETHYLENE GLYCOL 3350
>A> AA TEVA PHARMS 17GM/SCOOPFUL N77445 001 May 04, 2006 Apr NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVACHOL
>D> BRISTOL MYERS 10MG N19898 002 Oct 31, 1991 Apr CFTG
>A> AB 10MG N19898 002 Oct 31, 1991 Apr CFTG
>D> 20MG N19898 003 Oct 31, 1991 Apr CFTG
>A> AB 20MG N19898 003 Oct 31, 1991 Apr CFTG
>D> 40MG N19898 004 Mar 22, 1993 Apr CFTG
>A> AB 40MG N19898 004 Mar 22, 1993 Apr CFTG
>A> PRAVASTATIN SODIUM
>A> AB TEVA 10MG N76056 001 Apr 24, 2006 Apr NEWA
>A> AB 20MG N76056 002 Apr 24, 2006 Apr NEWA
>A> AB 40MG N76056 003 Apr 24, 2006 Apr NEWA
PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETHAZINE HYDROCHLORIDE
>A> AA VINTAGE 6.25MG/5ML N40643 001 Apr 26, 2006 Apr NEWA
SULFACETAMIDE SODIUM
SOLUTION/DROPS; OPHTHALMIC
SULFACETAMIDE SODIUM
>A> AT ALCON 30% N89068 001 May 05, 1987 Apr CAHN
>D> AT STERIS 30% N89068 001 May 05, 1987 Apr CAHN
SULFAMETHOXAZOLE; TRIMETHOPRIM
SUSPENSION; ORAL
BACTRIM PEDIATRIC
>D> @ MUTUAL PHARM 200MG/5ML;40MG/5ML N17560 002 Apr CMFD
>A> AB 200MG/5ML;40MG/5ML N17560 002 Apr CMFD
TECHNETIUM TC-99M APCITIDE
INJECTABLE; INJECTION
ACUTECT
>D> BERLEX LABS N/A N20887 001 Sep 14, 1998 Apr CAHN
>A> CIS BIO INTL SA N/A N20887 001 Sep 14, 1998 Apr CAHN
TECHNETIUM TC-99M DEPREOTIDE
INJECTABLE; INJECTION
NEO TECT KIT
>D> + BERLEX LABS N/A N21012 001 Aug 03, 1999 Apr CAHN
>A> + CIS BIO INTL SA N/A N21012 001 Aug 03, 1999 Apr CAHN
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
ACHROMYCIN V
>D> @ CLONMEL HLTHCARE 250MG N50278 003 Apr CAHN
>D> @ 500MG N50278 001 Apr CAHN
>A> @ SCIREG INTL INC 250MG N50278 003 Apr CAHN
>A> @ 500MG N50278 001 Apr CAHN
THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL
THEOPHYLLINE
>A> AB NOSTRUM 400MG N40595 001 Apr 21, 2006 Apr NEWA
>A> AB 600MG N40560 002 Apr 21, 2006 Apr NEWA
UNIPHYL
>D> + PURDUE FREDERICK 400MG N87571 001 Sep 01, 1982 Apr CTEC
>A> AB + 400MG N87571 001 Sep 01, 1982 Apr CTEC
>D> + 600MG N40086 001 Apr 15, 1996 Apr CTEC
>A> AB + 600MG N40086 001 Apr 15, 1996 Apr CTEC
UROKINASE
INJECTABLE; INJECTION
ABBOKINASE
>D> @ ABBOTT 5,000 IU/VIAL N21846 003 Apr CAHN
>D> @ 9,000 IU/VIAL N21846 002 Apr CAHN
>D> + 250,000 IU/VIAL N21846 001 Apr CAHN
>A> @ IMARX THERAP 5,000 IU/VIAL N21846 003 Apr CAHN
>A> @ 9,000 IU/VIAL N21846 002 Apr CAHN
>A> + 250,000 IU/VIAL N21846 001 Apr CAHN
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
>A> AB WATSON LABS 25MG N77650 001 Apr 20, 2006 Apr NEWA
>A> AB 50MG N77650 002 Apr 20, 2006 Apr NEWA
>A> AB 100MG N77650 003 Apr 20, 2006 Apr NEWA
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SPONGE; TOPICAL
CHLORAPREP WITH TINT
>A> + MEDI FLEX INC 2%;70% (10.5ML) N20832 005 Apr 03, 2006 Apr NEWA
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
>D> NICORETTE
>D> GLAXOSMITHKLINE EQ 2MG BASE N18612 003 Dec 23, 1998 Apr CTNA
>D> EQ 4MG BASE N20066 003 Dec 23, 1998 Apr CTNA
>A> NICORETTE (MINT)
>A> GLAXOSMITHKLINE EQ 2MG BASE N18612 003 Dec 23, 1998 Apr CTNA
>A> EQ 4MG BASE N20066 003 Dec 23, 1998 Apr CTNA
>A> NICOTINE POLACRILEX
>A> PERRIGO EQ 2MG BASE N76777 001 Sep 16, 2004 Apr CTNA
>A> EQ 2MG BASE N76776 001 Sep 16, 2004 Apr CTNA
>A> EQ 4MG BASE N76779 001 Sep 16, 2004 Apr CTNA
>A> EQ 4MG BASE N76778 001 Sep 16, 2004 Apr CTNA
>A> WATSON LABS EQ 2MG BASE N76569 001 Jul 29, 2004 Apr CTNA
>A> EQ 4MG BASE N76568 002 Jul 29, 2004 Apr CTNA
>D> NICOTINE POLACRILEX (MINT)
>D> PERRIGO EQ 2MG BASE N76777 001 Sep 16, 2004 Apr CTNA
>D> EQ 4MG BASE N76779 001 Sep 16, 2004 Apr CTNA
>D> WATSON LABS EQ 2MG BASE N76569 001 Jul 29, 2004 Apr CTNA
>D> EQ 4MG BASE N76568 002 Jul 29, 2004 Apr CTNA
>D> NICOTINE POLACRILEX (ORANGE)
>D> PERRIGO EQ 2MG BASE N76776 001 Sep 16, 2004 Apr CTNA
>D> EQ 4MG BASE N76778 001 Sep 16, 2004 Apr CTNA
Date created: May 15, 2006 |
|
